Loading clinical trials...
Loading clinical trials...
The purpose of the study is to measure RV ejection fraction (RVEF), pulmonary flow, and pulmonary perfusion before and after exposure to inhaled nitric oxide in patients with pulmonary arterial hypert...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanderbilt University
Collaborators
NCT06053580 · Pulmonary Arterial Hypertension, Right Heart Failure, and more
NCT05339087 · Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, and more
NCT06384534 · Pulmonary Vascular Disorder, Chronic Thromboembolic Pulmonary Hypertension, and more
NCT03101384 · Pulmonary Embolism, Pulmonary Embolism and Thrombosis, and more
Vanderbilt University Medical Center
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions